Ernest Nadal

51PUBLICATIONS
346CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jun 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|May 20, 2026
Metabolic vulnerabilities in pleural mesothelioma.

|Apr 10, 2026
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics.

Iswarya Sreeram, Sílvia Plans-Marin, Mabel Cruz-Rodríguez

|Mar 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer.

Natalia Díaz-Valdivia, Paula Duch, Rafael Ikemori

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

Pageof 9

Frequent Collaborators

8 joint publications

Alberto Cruz-Bermúdez

8 joint publications

Javier de Castro-Carpeño

8 joint publications

Mariano Provencio Pulla

7 joint publications

Alex Martínez-Martí